An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.

from Reuters: Health News https://reut.rs/2SmigH9
via IFTTT
from Reuters: Health News https://reut.rs/2SmigH9
via IFTTT
Post a Comment